Valuation: Edwards Lifesciences Corporation

Market Cap 54.6B 47.78B 44.03B 40.81B 77.48B 5,182B 78.72B 528B 205B 2,557B 205B 201B 8,839B P/E 2026 *
33.8x
P/E 2027 * 29x
Enterprise Value 51.12B 44.73B 41.22B 38.21B 72.53B 4,851B 73.7B 494B 192B 2,394B 192B 188B 8,275B EV / Sales 2026 *
7.57x
EV / Sales 2027 * 6.68x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day-0.38%
1 week+4.82%
Current month+4.82%
1 month+10.31%
3 months+17.29%
6 months+11.78%
Current year+11.23%
1 week 91.82
Extreme 91.82
96.29
1 month 83.17
Extreme 83.17
96.29
Current year 74.66
Extreme 74.66
96.29
1 year 72.3
Extreme 72.3
96.29
3 years 58.93
Extreme 58.93
96.29
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap.
30/06Fiscal year

Executive/Senior Manager

1,857 0.0003%
17/06Sell

Chief Executive Officer

-523 0.0001%
29/05Sell

Controller/Auditor

-568 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.38%+4.82%+23.64%+5.05% 54.8B
-0.19%+3.04%+23.39%+0.56% 192B
-1.28%+7.45%-20.09%+28.98% 153B
+0.29%+1.95%-2.73%-16.69% 137B
+1.57%+6.14%-56.37%-13.37% 66.29B
+1.06%+3.07%-24.36%-28.90% 44.44B
-1.05%-0.03%+8.13%+41.94% 37.2B
+0.41%-1.27%+9.97%+12.09% 36.89B
+0.62%+12.76%-14.30%+1.83% 31.5B
+0.08%+1.37%-13.03%-18.50% 29.5B
Average +0.11%+4.00%-6.57%+1.30% 78.33B
Weighted average by Cap. -0.08%+3.83%-3.37%+2.41%

Financials

2026 *2027 *
Net sales 6.75B 5.91B 5.44B 5.04B 9.58B 640B 9.73B 65.26B 25.38B 316B 25.33B 24.79B 1,092B 7.41B 6.48B 5.98B 5.54B 10.52B 703B 10.69B 71.66B 27.87B 347B 27.82B 27.22B 1,200B
Net income 1.62B 1.42B 1.31B 1.21B 2.3B 154B 2.34B 15.71B 6.11B 76.08B 6.1B 5.97B 263B 1.89B 1.65B 1.53B 1.41B 2.68B 179B 2.73B 18.29B 7.11B 88.58B 7.1B 6.95B 306B
Net Debt -3.48B -3.05B -2.81B -2.6B -4.94B -331B -5.02B -33.68B -13.1B -163B -13.07B -12.79B -564B -5.07B -4.44B -4.09B -3.79B -7.2B -481B -7.31B -49.05B -19.08B -238B -19.04B -18.63B -821B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
07/07/26 USD 94.82 -0.38% 4,445,101
06/07/26 USD 95.18 +0.86% 3,958,057
02/07/26 USD 94.37 +2.59% 3,206,400
01/07/26 USD 91.99 +1.69% 4,284,007
30/06/26 USD 90.46 -0.79% 3,627,318
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
94.82USD
Average target price
97.31USD
Spread / Average Target
+2.62%

Quarterly revenue - Rate of surprise